Mydecine Innovations Group (MYCOF) Short Interest Ratio & Short Volume $0.0040 0.00 (-31.03%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Mydecine Innovations Group Short Interest DataMydecine Innovations Group (MYCOF) has a short interest of 300 shares. This marks a -89.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 11,143 shares to cover all short positions.Current Short Interest300 sharesPrevious Short Interest2,900 sharesChange Vs. Previous Month-89.66%Dollar Volume Sold Short$1.17Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume2,701 sharesAverage Trading Volume11,143 sharesToday's Volume Vs. Average24% Short Selling Mydecine Innovations Group? Sign up to receive the latest short interest report for Mydecine Innovations Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMYCOF Short Interest Over TimeMYCOF Days to Cover Over TimeMYCOF Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Mydecine Innovations Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024300 shares $1.17 -89.7%N/A0 $0.00 10/15/20242,900 shares $17.98 No ChangeN/A1.8 $0.01 9/15/20244,000 shares $46.00 No ChangeN/A2.5 $0.01 5/31/2024100 shares $0.61 No ChangeN/A0 $0.01 5/15/2024100 shares $1.28 No ChangeN/A0 $0.01 4/30/2024100 shares $1.47 No ChangeN/A0 $0.01 Get the Latest News and Ratings for MYCOF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mydecine Innovations Group and its competitors with MarketBeat's FREE daily newsletter. 4/15/2024100 shares $1.72 No ChangeN/A0 $0.02 3/31/2024100 shares $0.93 No ChangeN/A0 $0.01 3/15/2024100 shares $1.28 -99.0%N/A0 $0.01 2/29/20249,900 shares $94.05 -5.7%N/A0.5 $0.01 2/15/202410,500 shares $101.85 -37.9%N/A0.2 $0.01 1/15/2024100 shares $1.81 No ChangeN/A0 $0.02 12/31/2023100 shares $1.49 No ChangeN/A0 $0.01 12/15/2023100 shares $7.04 No ChangeN/A0 $0.07 11/30/2023100 shares $8.66 No ChangeN/A0 $0.09 11/15/2023100 shares $9.00 No ChangeN/A0 $0.09 10/31/2023100 shares $5.26 -75.0%N/A0 $0.05 10/15/2023400 shares $46.20 -33.3%N/A0.4 $0.12 9/30/2023600 shares $54.09 +200.0%N/A0.1 $0.09 9/15/2023200 shares $29.12 No ChangeN/A0.1 $0.15 8/31/2023200 shares $22.56 No ChangeN/A0.2 $0.11 8/15/2023200 shares $20.34 No ChangeN/A0 $0.10 7/31/2023200 shares $23.10 No ChangeN/A0 $0.12 7/15/2023200 shares $20.74 No ChangeN/A0 $0.10 6/30/2023200 shares $32.54 No ChangeN/A0 $0.16 6/15/2023200 shares $40.00 No ChangeN/A0 $0.20 5/31/2023200 shares $41.42 -94.3%N/A0 $0.21 5/15/20233,500 shares $813.75 +52.2%N/A0.2 $0.23 4/30/20232,300 shares $552.00 -77.2%N/A0 $0.24 4/15/202310,100 shares $5,256.04 -64.9%N/A0 $0.52 3/31/202328,800 shares $13,348.80 +1,152.2%N/A0.5 $0.46 3/15/20232,300 shares $828.00 +666.7%N/A0.1 $0.36 2/28/2023300 shares $120.00 -50.0%N/A0 $0.40 2/15/2023600 shares $258.00 No ChangeN/A0.1 $0.43 1/31/2023600 shares $282.00 +200.0%N/A0 $0.47 1/15/2023200 shares $87.64 -33.3%N/A0 $0.44 12/30/2022300 shares $129.00 +50.0%N/A0 $0.43 12/15/2022200 shares $78.08 No ChangeN/A0 $0.39 11/30/2022200 shares $90.90 -98.7%N/A0 $0.45 11/15/202214,900 shares $6,556.00 +7,350.0%N/A0.3 $0.44We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 10/31/2022200 shares $102.00 -99.0%N/A0 $0.51 10/15/202219,300 shares $10,036.00 -37.7%N/A0.8 $0.52 9/30/202231,000 shares $16,740.00 +74.2%N/A0.9 $0.54 9/15/202217,800 shares $9,790.00 -9.2%N/A0.8 $0.55 8/31/202219,600 shares $10,780.00 No ChangeN/A0.6 $0.55 8/15/202219,600 shares $11,368.00 +53.1%N/A0.7 $0.58 7/31/202212,800 shares $7,270.78 +2,033.3%N/A0.3 $0.57 7/15/2022600 shares $402.00 -50.0%N/A0 $0.67 6/30/20221,200 shares $768.00 +20.0%N/A0 $0.64 6/15/20221,000 shares $820.00 -96.8%N/A0 $0.82 5/31/202231,300 shares $22,849.00 No ChangeN/A1 $0.73 4/15/20227,400 shares $13,320.00 -34.5%N/A0 $1.80 3/31/202211,300 shares $916.43 -56.5%N/A0 $0.08 3/15/202226,000 shares $2,428.40 +147.6%N/A0 $0.09 2/28/202210,500 shares $1,228.50 +26.5%N/A0 $0.12 2/15/20228,300 shares $1,033.35 -75.2%N/A0 $0.12 1/31/202233,400 shares $4,943.20 +9.2%N/A0 $0.15 1/15/202230,600 shares $6,426.00 +611.6%N/A0 $0.21 12/31/20214,300 shares $473.86 +616.7%N/A0 $0.11 12/15/2021600 shares $67.80 -98.5%N/A0 $0.11 11/30/202141,200 shares $5,974.00 +45.6%N/A0 $0.15 11/15/202128,300 shares $4,952.50 -31.0%N/A0 $0.18 10/29/202141,000 shares $9,840.00 -52.1%N/A0 $0.24 10/15/202185,600 shares $23,856.72 -59.0%N/A0.1 $0.28 9/30/2021208,900 shares $55,274.94 +12,956.3%N/A0.2 $0.26 9/15/20211,600 shares $449.60 -60.0%N/A0 $0.28 8/31/20214,000 shares $1,480.00 -97.5%N/A0 $0.37 8/13/2021162,800 shares $66,096.80 +702.0%N/A0.1 $0.41 7/30/202120,300 shares $7,683.55 -94.8%N/A0 $0.38 7/15/2021390,900 shares $152,763.72 +2,884.0%N/A0.1 $0.39 6/30/202113,100 shares $4,058.38 +385.2%N/A0 $0.31 6/15/20212,700 shares $652.59 -3.6%N/A0 $0.24 5/28/20213,800 shares $1,054.31 +3,700.0%N/A0 $0.28 5/14/2021100 shares $28.80 -99.9%N/A0 $0.29 4/30/2021127,400 shares $43,940.26 +1,125.0%N/A0.1 $0.34 4/15/202110,400 shares $2,776.80 -32.9%N/A0 $0.27 3/31/202115,500 shares $4,727.50 -79.2%N/A0 $0.31 3/15/202174,400 shares $25,973.04 +1,100.0%N/A0 $0.35 2/26/20216,200 shares $2,538.90 -98.0%N/A0 $0.41 2/12/2021305,200 shares $121,164.40 +16.5%N/A0.1 $0.40 1/29/2021261,900 shares $103,267.17 +229.4%N/A0.2 $0.39 1/15/2021403,500 shares $170,155.95 +872.3%N/A0.2 $0.42 12/31/202066,200 shares $22,501.38 -83.6%N/A0 $0.34 12/15/2020403,500 shares $189,645.00 +872.3%N/A0.2 $0.47 11/30/202041,500 shares $17,430.00 -74.1%N/A0.1 $0.42 MYCOF Short Interest - Frequently Asked Questions What is Mydecine Innovations Group's current short interest? Short interest is the volume of Mydecine Innovations Group shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 300 shares of MYCOF short. Learn More on Mydecine Innovations Group's current short interest. Is Mydecine Innovations Group's short interest increasing or decreasing? Mydecine Innovations Group saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 300 shares, a decrease of 89.7% from the previous total of 2,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mydecine Innovations Group's short interest compare to its competitors? Here is how the short interest of companies compare to Mydecine Innovations Group: Coca-Cola FEMSA, S.A.B. de C.V. (0.64%), Coca-Cola Europacific Partners PLC (1.49%), Fomento Económico Mexicano, S.A.B. de C.V. (0.59%), Celsius Holdings, Inc. (11.67%), Primo Water Co. (2.85%), Zevia PBC (1.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Mydecine Innovations Group stock? Short selling MYCOF is an investing strategy that aims to generate trading profit from Mydecine Innovations Group as its price is falling. MYCOF shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mydecine Innovations Group? A short squeeze for Mydecine Innovations Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYCOF, which in turn drives the price of the stock up even further. How often is Mydecine Innovations Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYCOF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies COCSF Short Squeeze KOF Short Squeeze CCEP Short Squeeze FMX Short Squeeze CELH Short Squeeze ZVIA Short Squeeze TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MYCOF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mydecine Innovations Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mydecine Innovations Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.